Han B - Search Results

1

Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment.

Wang J, Zhao Y, Wang Q, Zhang L, Shi J, Wang Z, Cheng Y, He J, Shi Y, Yu H, Zhao Y, Chen W, Luo Y, Wang X, Nan K, Jin F, Dong J, Li B, Liu Z, Han B, Li K. Wang J, et al. Among authors: han b. Cancer Biol Med. 2018 Nov;15(4):443-451. doi: 10.20892/j.issn.2095-3941.2018.0158. Cancer Biol Med. 2018. PMID: 30766754 Free PMC article.

2

Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis.

Gu P, Zhao YZ, Jiang LY, Zhang W, Xin Y, Han BH. Gu P, et al. Eur J Cancer. 2009 May;45(8):1389-96. doi: 10.1016/j.ejca.2008.11.043. Epub 2009 Jan 3. Eur J Cancer. 2009. PMID: 19124238 Review.

3

[The Clinical Analysis of 21 Patients with Lymphoepithelioma-like Carcinoma after Operation.].

Xia J, Jiang L, Zhang J, Miao Q, Xin Y, Zhong R, Zhao Y, Han B. Xia J, et al. Among authors: han b. Zhongguo Fei Ai Za Zhi. 2009 Nov 20;12(11):1169-73. doi: 10.3779/j.issn.1009-3419.2009.11.08. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20723365 Free article. Chinese.

4

[A primary study of immunotherapy with carcinoembryonic antigen peptide-pulsed, autologous human cultured dendritic cells in patients with advanced non-small cell lung cancer].

Han B, Zhong H, Fan X, Feng G, Li R, Gong L, Chu T, Zhang W, Jin B, Shi C, Zhao Y, Sha H, Dong Q, Liao M. Han B, et al. Zhongguo Fei Ai Za Zhi. 2006;9(4):340-4. doi: 10.3779/j.issn.1009-3419.2006.04.09. Zhongguo Fei Ai Za Zhi. 2006. PMID: 21176451 Free article. Chinese.

5

[Comparative study on gemcitabine plus cisplatin and vinorelbine plus ifosfamide plus cisplatin combined chemotherapy in the treatment of advanced non-small cell lung cancer].

Zhao Y, Chen Y, Ji H, Chu T, Han B, Liao M. Zhao Y, et al. Among authors: han b. Zhongguo Fei Ai Za Zhi. 2004 Oct 20;7(5):449-51. doi: 10.3779/j.issn.1009-3419.2004.05.18. Zhongguo Fei Ai Za Zhi. 2004. PMID: 21244803 Free article. Chinese.

6

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of paclitaxel-carboplatin alone or with endostar for advanced non-small cell lung cancer.

Han B, Xiu Q, Wang H, Shen J, Gu A, Luo Y, Bai C, Guo S, Liu W, Zhuang Z, Zhang Y, Zhao Y, Jiang L, Zhou J, Jin X. Han B, et al. J Thorac Oncol. 2011 Jun;6(6):1104-9. doi: 10.1097/JTO.0b013e3182166b6b. J Thorac Oncol. 2011. PMID: 21532504 Free article. Clinical Trial.

7

Chinese guidelines on the diagnosis and treatment of primary lung cancer (2011).

Zhi XY, Wu YL, Bu H, Cheng G, Cheng Y, Du X, Han BH, Jiang GN, Jiao SC, Liu DR, Liu LX, Lu Y, Ma SL, Shi YK, Wang CL, Wang J, Wang TY, Yang Y, Zhou QH; Lung Cancer Diagnosis and Treatment Expert Panel of the Chinese Ministry of Health. Zhi XY, et al. J Thorac Dis. 2012 Feb;4(1):88-101. doi: 10.3978/j.issn.2072-1439.2010.08.01. J Thorac Dis. 2012. PMID: 22295172 Free PMC article. No abstract available.

8

[A multicenter, randomized, double-blind, placebo-controlled safety study to evaluate the clinical effects and quality of life of paclitaxel-carboplatin (PC) alone or combined with endostar for advanced non-small cell lung cancer (NSCLC)].

Han BH, Xiu QY, Wang HM, Shen J, Gu AQ, Luo Y, Bai CX, Guo SL, Liu WC, Zhuang ZX, Zhang Y, Zhao YZ, Jiang LY, Shi CL, Jin B, Zhou JY, Jin XQ. Han BH, et al. Zhonghua Zhong Liu Za Zhi. 2011 Nov;33(11):854-9. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22335953 Clinical Trial. Chinese.

9

Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial.

Zhang L, Ma S, Song X, Han B, Cheng Y, Huang C, Yang S, Liu X, Liu Y, Lu S, Wang J, Zhang S, Zhou C, Zhang X, Hayashi N, Wang M; INFORM investigators. Zhang L, et al. Among authors: han b. Lancet Oncol. 2012 May;13(5):466-75. doi: 10.1016/S1470-2045(12)70117-1. Epub 2012 Apr 17. Lancet Oncol. 2012. PMID: 22512843 Clinical Trial.

10

Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.

Hu L, Wu C, Zhao X, Heist R, Su L, Zhao Y, Han B, Cao S, Chu M, Dai J, Dong J, Shu Y, Xu L, Chen Y, Wang Y, Lu F, Jiang Y, Yu D, Chen H, Tan W, Ma H, Chen J, Jin G, Wu T, Lu D, Christiani DC, Lin D, Hu Z, Shen H. Hu L, et al. Among authors: han b. Clin Cancer Res. 2012 Oct 1;18(19):5507-14. doi: 10.1158/1078-0432.CCR-12-1202. Epub 2012 Aug 7. Clin Cancer Res. 2012. PMID: 22872573 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,853 results

Search Page

Filters